Finanzwire Finanzwire
Basculer en Français
11243 Companies
249510 Keywords
177604 Articles
135336 Press releases
Headlines Articles Press releases Zuellig Pharma Remove
  1. Home
  2. Companies
  3. Zuellig Pharma
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 02:50, 10 months 28 days ago

    Zuellig Pharma Launches Cutting-Edge Clinical Trial Support Center in South Korea

    Automation Clinical Trials South Korea Healthcare Logistics Zuellig Pharma
  • PRESS RELEASE

    published on 12/01/2025 at 02:45, 10 months 28 days ago

    Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needs

    Zuellig Pharma opens a state-of-the-art Clinical Trial Support Innovation Center in South Korea, enhancing clinical logistics with automation and stringent compliance standards
    Logistics Automation Healthcare Clinical Trials Zuellig Pharma
    Logo of Zuellig Pharma
  • PRESS RELEASE

    published on 08/01/2023 at 10:00, 3 years 2 months ago

    Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

    Logo of Zuellig Pharma
Accesswire
  • Published on 10/28/2026 at 22:35, 6 hours 24 minutes ago

    Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification

  • Published on 10/28/2026 at 12:30, 16 hours 29 minutes ago

    Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th

  • Published on 10/28/2026 at 12:30, 16 hours 29 minutes ago

    AI/ML Innovations Announces Advance Notice Provisions

  • Published on 10/28/2026 at 12:30, 16 hours 29 minutes ago

    Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out

  • Published on 10/28/2026 at 12:30, 16 hours 29 minutes ago

    Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq

View all ACCESSWIRE
EQS Group
  • Published on 10/29/2026 at 00:15, 4 hours 44 minutes ago

    Infinite Electronics Showcases Engineered Connectivity Solutions at electronica 2026

  • Published on 10/28/2026 at 21:35, 7 hours 24 minutes ago

    Food & Beverage Manufacturers Race to Scale AI Beyond the Pilot Stage

  • Published on 10/28/2026 at 21:15, 7 hours 44 minutes ago

    Amrize Reports Third Quarter 2026 Results

  • Published on 10/28/2026 at 21:15, 7 hours 44 minutes ago

    Amrize Completes $1 Billion Share Repurchase Program

  • Published on 10/28/2026 at 20:36, 8 hours 22 minutes ago

    Vonovia’s Core Business Remains Resilient as Higher Financing Costs and Weaker Transaction Business Shape 2027 Guidance and 2028 Objectives

View all EQS
Les Echos
  • Published on 10/28/2026 at 18:09, 10 hours 49 minutes ago

    Share buyback mandate

  • Published on 10/28/2026 at 17:45, 11 hours 14 minutes ago

    VOGO obtains FIBA (International Basketball Federation) Approval for its Instant Replay System.

  • Published on 10/28/2026 at 17:45, 11 hours 14 minutes ago

    Successful issue of a € 6.0 billion bond as part of the financing of the PTC acquisition

  • Published on 10/28/2026 at 17:45, 11 hours 14 minutes ago

    Groupe CRIT : Revenue over 9 months 2026 : €2.55 billion (+2.2% organic growth).

  • Published on 10/28/2026 at 17:45, 11 hours 14 minutes ago

    Infotel : Acceleration of growth in Q3 2026: €77.9m (+11.3%). Confirmation of growth and profitability targets for 2026 as a whole.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy